CVE-2021-1623

Cisco IOS XE Software for Cisco cBR-8 Converged Broadband Routers Simple Network Management Protocol Denial of Service Vulnerability

Description

A vulnerability in the Simple Network Management Protocol (SNMP) punt handling function of Cisco cBR-8 Converged Broadband Routers could allow an authenticated, remote attacker to overload a device punt path, resulting in a denial of service (DoS) condition. This vulnerability is due to the punt path being overwhelmed by large quantities of SNMP requests. An attacker could exploit this vulnerability by sending a large number of SNMP requests to an affected device. A successful exploit could allow the attacker to overload the device punt path, resulting in a DoS condition.

Category

7.7
CVSS
Severity: High
CVSS 3.1 •
CVSS 2.0 •
EPSS 0.34%
Vendor Advisory cisco.com
Affected: Cisco Cisco IOS XE Software
Published at:
Updated at:

References

Frequently Asked Questions

What is the severity of CVE-2021-1623?
CVE-2021-1623 has been scored as a high severity vulnerability.
How to fix CVE-2021-1623?
To fix CVE-2021-1623, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2021-1623 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2021-1623 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2021-1623?
CVE-2021-1623 affects Cisco Cisco IOS XE Software.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.